|
Details
|
Specifications
|
|---|---|
|
CAS Number
|
1691249-45-2
|
|
Molecular Formula
|
C27H29N5O3
|
|
Molecular Weight
|
471.55 g/mol.
|
|
Synonyms
|
(S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxy phenyl)4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide.
|
|
Chemical Name
|
4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl) oxolan-2-yl] pyrimidin-2-one; hydrochloride
|
|
Therapeutic use
|
Zanubrutinib is a kinase inhibitor used to treat mantle cell lymphoma, a type of B-cell non-Hodgkin lymphoma, in adults who previously received therapy.
|
|
Status
|
Tech pack available
|
|
Background
|
Zanubrutinib (marketed as Brukinsa) is a next-generation, oral, small-molecule inhibitor of Bruton?s tyrosine kinase (BTK) developed by BeiGene. It was designed to specifically target BTK to treat various B-cell malignancies.
|
|
Grade
|
In-house
|
|
Polymorph
|
Form A and Amorphous
|
|
Storage Temperature
|
Form A: Controlled room temperature (20?C ? 25?C) | Amorphous: Controlled temperature at 2?C ? 8?C.
|
Please Note: We partner exclusively with pharmaceutical manufacturers, biotech companies, and international trading firms. Minimum order quantities apply*Â
Disclaimer:Â
The information provided on this webpage is based on the best available knowledge at the time of publication; however, accuracy and completeness are not guaranteed. Product specifications may change without notice. It is the responsibility of the purchaser or user to verify suitability and compliance. This product is intended for research use only and is not approved for human consumption.
Happy Customers
Projects Successfully Completed
Established
PhD Experts Driving R&D Excellence
Team Size
World-Class API Manufacturing Sites
Global Audits Successfully Completed
Comprehensive CDMO Service Offerings
Everything You Need to Know About Shilpa Pharma
Please Note: We partner exclusively with pharmaceutical manufacturers, biotech companies, and international trading firms. Minimum order quantities apply*
